The trademark application ACUITAS THERAPEUTICS was filed by Acuitas Therapeutics, Inc., a corporation established under the laws of Canada (the "Applicant"). The application was published for oppositions on March 28, 2023, and it was registered by office on July 5, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Change of name and address of the trademark registration was recorded on October 22, 2024. Change of name and address of the trademark registration was recorded on November 13, 2024. Change of name and address of the trademark registration was recorded on November 13, 2024.
Goods And Services
The mark was filed in class 1 with Lipids, lipid nanoparticles, lipid formulations, and nucleic acids, including messenger RNA, for scientific purposes, research purposes, or laboratory use.
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations, such as, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics
Pharmaceutical preparations comprised of nucleic acids, including messenger RNA, and lipid nanoparticles
Pharmaceutical preparations comprised of lipid nanoparticles
Pharmaceutical preparations, such as, vaccines for human use
Pharmaceutical preparations for gene silencing, for gene editing, for antibody therapeutics, for protein replacement therapeutics, and for nucleic acid therapeutics.
The mark was filed in class 42 with following description of goods:
Research, development, and evaluation services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology
Synthetic chemistry services, such as, design, synthesis, analysis, evaluation, and biophysical characterization of lipids, lipid formulations, and lipid nanoparticles
Preclinical study services, such as, conducting pharmacodynamic and pharmacokinetic studies, safety and tolerability studies regarding clinical pathology and histopathology, immune response characterization studies, and bioanalytical services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, and nucleic acid therapeutics
Clinical research services, such as, chemical molecular analysis, product optimization, and clinical trial services to pharmaceutical industries
Research and development of new formulation products for others
Research and development of new pharmaceuticals, medical therapies, vaccines, gene therapies, drug delivery agents, and nucleic acid therapeutics for others
Project management services for research and development programs in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology
Consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology.
The mark was filed in class 45 with Regulatory compliance consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid nanoparticles, nucleic acid, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology.